Cardio Diagnostics Holdings, Inc.
CDIO
$0.5199
$0.062613.69%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Revenue | -15.09% | -34.00% | 364.71% | -- | 430.00% |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -15.09% | -34.00% | 364.71% | -- | 430.00% |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -15.09% | -34.00% | 364.71% | -- | 430.00% |
SG&A Expenses | -1.64% | -0.37% | -49.63% | 158.01% | -34.51% |
Depreciation & Amortization | 10.42% | 0.00% | 0.00% | 0.00% | 20.00% |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | -1.71% | -2.66% | -49.50% | 145.08% | -34.96% |
Operating Income | 1.66% | 2.44% | 49.77% | -144.14% | 35.16% |
Income Before Tax | -9.39% | 26.90% | 67.98% | -303.22% | 41.60% |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -9.39% | 26.90% | 67.98% | -303.22% | 41.60% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -9.39% | 26.90% | 67.98% | -303.22% | 41.60% |
EBIT | 1.66% | 2.44% | 49.77% | -144.14% | 35.16% |
EBITDA | 3.26% | 5.52% | 52.86% | -143.17% | 37.65% |
EPS Basic | 47.26% | 64.39% | 85.49% | -82.53% | 70.79% |
Normalized Basic EPS | 59.97% | 66.39% | 84.06% | -82.69% | 61.46% |
EPS Diluted | 47.26% | 64.39% | 85.49% | -82.53% | 70.79% |
Normalized Diluted EPS | 59.97% | 66.39% | 84.06% | -82.69% | 61.46% |
Average Basic Shares Outstanding | 107.26% | 105.34% | 120.73% | 120.77% | 99.91% |
Average Diluted Shares Outstanding | 107.26% | 105.34% | 120.73% | 120.77% | 99.91% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |